Deutsche Bank Sees Upside in Chelsea Therapeutics (CHTP) to $9 On FDA Approval
Tweet Send to a FriendGet Alerts CHTP Hot Sheet
Price: $1.84 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 25 | New: 12
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 25 | New: 12
Trade CHTP Now!
Deutsche Bank commented on Chelsea Therapeutics (NASDAQ: CHTP) following FDA panel backing of Northera and sees upside to $9/share.
The firm comments, "Most who voted No believe longer studies need to be conducted. All doctors believe a confirmatory trial is warranted. This, combined with an SPA & a very rare/sick patient population is a positive event for CHTP. Risk/reward into APPROVAL is 50% downside (~$1.50) and ~400% upside (~$9/share)."
The firm has a Buy rating and $9 target on CHTP.
For an analyst ratings summary and ratings history on Chelsea Therapeutics click here. For more ratings news on Chelsea Therapeutics click here.
Shares of Chelsea Therapeutics closed at $2.41 yesterday, with a 52 week range of $2.18-$6.06.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm comments, "Most who voted No believe longer studies need to be conducted. All doctors believe a confirmatory trial is warranted. This, combined with an SPA & a very rare/sick patient population is a positive event for CHTP. Risk/reward into APPROVAL is 50% downside (~$1.50) and ~400% upside (~$9/share)."
The firm has a Buy rating and $9 target on CHTP.
For an analyst ratings summary and ratings history on Chelsea Therapeutics click here. For more ratings news on Chelsea Therapeutics click here.
Shares of Chelsea Therapeutics closed at $2.41 yesterday, with a 52 week range of $2.18-$6.06.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
- Best Buy (BBY) Numbers Raised at Jefferies Post Q1
- Needham & Company Boosts PT on Pandora (P), Sees 23% Upside
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Deutsche Bank
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
